Niranjan Y. Sardesai, PhD
CEO & President, Founder
Dr. Sardesai founded Geneos to focus on personalized immunotherapies for cancer after building Inovio Pharmaceuticals into a Phase III cancer and infectious disease immunotherapy company serving as its Chief Operating Officer. At Inovio, he held positions of increasing responsibility where he helped formulate the company’s product development and growth strategies and reorganized the company into a DNA vaccine and immunotherapies company. He led and served as the PI on multiple large multi-institutional program project grants from govt and non-govt funding agencies and private partnerships and was responsible for raising and managing over $150M in non-dilutive funding via grants and partnerships. Dr. Sardesai drove multiple M&A and licensing transactions to consolidate key technologies, establish the corporate footprint, and develop its immunotherapies platform and product pipeline. He led the strategic out-licensing of Inovio’s pipeline products to secure major licensing deals totaling over $1 Bn with pharma partners.
Dr. Sardesai was previously the founder and President of NVision Consulting Inc., a firm providing strategic counsel to entrepreneurial life sciences companies. He served as Director of Research and Development at Fujirebio Diagnostics, Inc., where he oversaw the expansion of the company’s oncology portfolio. Products developed under his leadership include groundbreaking new tests for mesothelioma (MESOMARK™), bladder cancer and a multi-marker test for ovarian cancer (HE4).
Dr. Sardesai received a PhD in Chemistry from the California Institute of Technology and a MBA (entrepreneurship and finance) from the Wharton School of the University of Pennsylvania, where he was the recipient of the Shils-Zeidman Award in Entrepreneurship. He was awarded fellowships at the Scripps Research Institute and the Massachusetts Institute of Technology (MIT). Dr. Sardesai received his Bachelor and Master of Science degrees in Chemistry from the Indian Institute of Technology, Mumbai. Dr. Sardesai has authored over 120 peer-reviewed manuscripts, has been granted multiple patents, and was recognized by PharmaVoice magazine as one of the top 100 most influential and inspirational leaders across the life sciences industry (2015). He lives in Blue Bell, PA with his wife and their two sons they are raising to be responsible global citizens.
CEO & President, Founder
Dr. Sardesai founded Geneos to focus on personalized immunotherapies for cancer after building Inovio Pharmaceuticals into a Phase III cancer and infectious disease immunotherapy company serving as its Chief Operating Officer. At Inovio, he held positions of increasing responsibility where he helped formulate the company’s product development and growth strategies and reorganized the company into a DNA vaccine and immunotherapies company. He led and served as the PI on multiple large multi-institutional program project grants from govt and non-govt funding agencies and private partnerships and was responsible for raising and managing over $150M in non-dilutive funding via grants and partnerships. Dr. Sardesai drove multiple M&A and licensing transactions to consolidate key technologies, establish the corporate footprint, and develop its immunotherapies platform and product pipeline. He led the strategic out-licensing of Inovio’s pipeline products to secure major licensing deals totaling over $1 Bn with pharma partners.
Dr. Sardesai was previously the founder and President of NVision Consulting Inc., a firm providing strategic counsel to entrepreneurial life sciences companies. He served as Director of Research and Development at Fujirebio Diagnostics, Inc., where he oversaw the expansion of the company’s oncology portfolio. Products developed under his leadership include groundbreaking new tests for mesothelioma (MESOMARK™), bladder cancer and a multi-marker test for ovarian cancer (HE4).
Dr. Sardesai received a PhD in Chemistry from the California Institute of Technology and a MBA (entrepreneurship and finance) from the Wharton School of the University of Pennsylvania, where he was the recipient of the Shils-Zeidman Award in Entrepreneurship. He was awarded fellowships at the Scripps Research Institute and the Massachusetts Institute of Technology (MIT). Dr. Sardesai received his Bachelor and Master of Science degrees in Chemistry from the Indian Institute of Technology, Mumbai. Dr. Sardesai has authored over 120 peer-reviewed manuscripts, has been granted multiple patents, and was recognized by PharmaVoice magazine as one of the top 100 most influential and inspirational leaders across the life sciences industry (2015). He lives in Blue Bell, PA with his wife and their two sons they are raising to be responsible global citizens.
Speaking In
11:00 AM - 12:00 PM (PDT)
Tuesday, October 13
More than half of biotech CEOs are first-time CEOs, but even the most experienced leadership teams…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
